3 days ago · Veru's drug conserves muscle mass for older patients taking Novo's Wegovy in phase 2 trial

3 days ago · An investigational drug from Veru helped preserve lean mass in patients taking Wegovy, though some experts raised questions about the treatment.

Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction

3 days ago · An experimental muscle-building drug helped people with obesity taking Wegovy preserve significantly more lean mass than Wegovy alone in a 16-week trial, the drug’s …

3 days ago · Veru said on Monday its experimental drug in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting …

(Reuters) -Veru said on Monday its experimental drug, in combination with Novo Nordisk's weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the …

3 days ago · -- Study met primary endpoint: Enobosarm treatment resulted in statistically significant reduction in the loss of lean mass in subjects receiving WEGOVY (p=0.002) -- -- …

3 days ago · Patients taking Novo Nordisk’s Wegovy plus Veru’s enobosarm saw 71% lower lean mass loss than those who were taking Wegovy alone but investors await more data.

3 days ago · Enobosarm treatment significantly preserves lean mass and enhances fat loss in older patients using WEGOVY, according to a Phase 2b study. Quiver AI Summary Veru Inc. …

Veru intends to conduct a Phase 2b multicenter, double-blind, placebo-controlled, randomized, and dose-finding obesity or overweight clinical study in approximately 75 patients who qualify …